1. Home
  2. APLM vs GURE Comparison

APLM vs GURE Comparison

Compare APLM & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • GURE
  • Stock Information
  • Founded
  • APLM 2016
  • GURE 2006
  • Country
  • APLM United States
  • GURE China
  • Employees
  • APLM N/A
  • GURE N/A
  • Industry
  • APLM Blank Checks
  • GURE Major Chemicals
  • Sector
  • APLM Finance
  • GURE Industrials
  • Exchange
  • APLM Nasdaq
  • GURE Nasdaq
  • Market Cap
  • APLM 6.5M
  • GURE 7.3M
  • IPO Year
  • APLM N/A
  • GURE 1992
  • Fundamental
  • Price
  • APLM $5.68
  • GURE $0.63
  • Analyst Decision
  • APLM Strong Buy
  • GURE
  • Analyst Count
  • APLM 1
  • GURE 0
  • Target Price
  • APLM $200.00
  • GURE N/A
  • AVG Volume (30 Days)
  • APLM 25.0K
  • GURE 1.0M
  • Earning Date
  • APLM 04-03-2025
  • GURE 04-11-2025
  • Dividend Yield
  • APLM N/A
  • GURE N/A
  • EPS Growth
  • APLM N/A
  • GURE N/A
  • EPS
  • APLM N/A
  • GURE N/A
  • Revenue
  • APLM $198,000.00
  • GURE $7,661,010.00
  • Revenue This Year
  • APLM $415.15
  • GURE N/A
  • Revenue Next Year
  • APLM N/A
  • GURE N/A
  • P/E Ratio
  • APLM N/A
  • GURE N/A
  • Revenue Growth
  • APLM N/A
  • GURE N/A
  • 52 Week Low
  • APLM $4.71
  • GURE $0.50
  • 52 Week High
  • APLM $42.00
  • GURE $1.79
  • Technical
  • Relative Strength Index (RSI)
  • APLM 40.12
  • GURE 42.00
  • Support Level
  • APLM $5.90
  • GURE $0.56
  • Resistance Level
  • APLM $6.88
  • GURE $0.64
  • Average True Range (ATR)
  • APLM 0.60
  • GURE 0.06
  • MACD
  • APLM 0.01
  • GURE -0.01
  • Stochastic Oscillator
  • APLM 13.17
  • GURE 34.05

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

Share on Social Networks: